Atrial Fibrillation
VIDEO: Women with AF challenging to manage
RANCHO PALOS VERDES, Calif. — In this Healio video exclusive, Ulrika Birgersdotter-Green, MD, discusses the “unique differences” between men and women with atrial fibrillation.
Abelacimab receives FDA fast track designation for stroke prevention in AF
Anthos Therapeutics announced abelacimab, a fully human monoclonal antibody inhibiting factor XI, received fast track designation from the FDA for an indication to prevent stroke and systemic embolism in patients with atrial fibrillation.
Mapping catheter for cardiac arrythmias cleared, launched
Biosense Webster announced the launch of an FDA-cleared catheter with novel technology for mapping cardiac arrythmias, including atrial fibrillation.
FDA expands LAA closure device labeling to include 45-day DAPT option
Boston Scientific announced the FDA indication for its left atrial appendage closure device has been expanded to include a 45-day dual antiplatelet therapy option after treatment of patients with nonvalvular atrial fibrillation.
Implantable loop recorder screening for AF not linked to stroke reduction risk
Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke compared with usual care, according to study results published in JAMA Neurology.
Smartphone-based screening doubles detection rate of treatment-relevant AF
Among middle-aged and older adults at increased risk for stroke, home-based digital screening using a smartphone more than doubled the detection rate of treatment-relevant atrial fibrillation vs. usual care.
INVICTUS trial supports vitamin K antagonists for rheumatic heart disease-associated AF
In patients with rheumatic heart disease-associated atrial fibrillation, vitamin K antagonist therapy was associated with a lower rate of ischemic stroke and mortality compared with rivaroxaban, without increasing risk for major bleeding.
Supraventricular arrhythmias more common than thought after percutaneous PFO closure
Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ovale closure for stroke prevention, researchers reported at the European Society of Cardiology Congress.
APPLE scoring system may be best predictor of AF recurrence after surgical ablation
The APPLE scoring system is superior to CHA2DS2‐VASc and CHADS2 in predicting atrial fibrillation recurrence after surgical ablation, data from a retrospective study show.
Atrial fibrillation in acute PE common, associated with increased mortality
A new analysis in Respiratory Medicine found that about one in eight patients with acute pulmonary embolism also have atrial fibrillation, which was associated with increased short- and long-term mortality.